MedTrace Logo

Validation of [18F]FES for Imaging of Brain Estrogen Receptors

NCT01842217 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2024-04-18

No results posted yet for this study

Summary

Validation of \[18F\]-FES for imaging of estrogen receptors in the brain

The primary objective of the study is to determine if \[18F\]-FES Positron Emission Tomography (PET) can be used to quantify the estrogen receptor expression in the human brain.

Conditions

  • Psychiatric/Mood Disorder | Patient
  • Estrogen Receptor Levels
  • Premenopausal
  • Postmenopausal

Interventions

PROCEDURE

FES-PET

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Andor Glaudemans, MD · University Medical Center Groningen

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01842217 on ClinicalTrials.gov